Revision: Feb. 19, 2026, 1:20 p.m.
Rep. Kesselring, Hills. 18
Rep. Cole, Hills. 26
Rep. Layon, Rock. 13
Rep. D. McGuire, Merr. 14
Rep. Bernardy, Rock. 36
Rep. Notter, Hills. 12
Rep. Ulery, Hills. 13
Rep. Reinfurt, Hills. 29
Rep. Morton, Hills. 39
February 19, 2026
2026-0850h
05/08
Floor Amendment to HB 1735-FN
Amend RSA 126-Z:1, I-b as inserted by section 1 of the bill by replacing it with the following:
[I-c.] I-b. "Individualized investigational treatment" means drugs, biologics, or devices unique to and produced exclusively for use for an individual patient, based on their own genetic profile, including but not limited to individualized gene therapy antisense oligonucleotides (ASO), individualized neoantigen vaccines, and any other individualized treatment.